Seiler N, Sarhan S, Knödgen B, Gerhart F
Merrell Dow Research Institute, Strasbourg-Center, France.
J Cancer Res Clin Oncol. 1988;114(1):71-80. doi: 10.1007/BF00390488.
The objective of this work was to study certain metabolic aspects of fluorine-substituted analogues of natural polyamines in healthy experimental animals, with the aim of exploring their potential application as tumor markers. Tissue polyamine concentrations were more effectively depleted by combined treatment with D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, and N1,N4-bis-allenylputrescine, an inactivator of polyamine oxidase, than with either inhibitor alone. This suggests the general importance of polyamine interconversion as a metabolic source of putrescine. Administration of 2,2-difluoroputrescine after 2 weeks pretreatment with the two inhibitors caused the formation of 6,6-difluorospermidine and 6,6-difluorospermidine in nearly all tissues. Highest concentrations of the chain-fluorinated polyamines were observed in the small intestine. At 24 h after 2,2-difluoroputrescine administration the amount was about 8% of the normal endogenous polyamine pool in the small intestine, but lower in all other tissues. Replenishment of endogenous polyamine pools is a relatively slow process. Approximately 9 days after cessation of treatment with the two inhibitors normal values had been reestablished. The rate of formation of endogenous polyamines was not affected by the presence of their difluoro analogues. Elimination of the chain-fluorinated polyamines from tissues seems not to follow normal polyamine metabolic patterns. Their most rapid elimination coincides with the enhancement of endogenous polyamines, indicating that the fluoro analogues are displaced by the natural polyamines. Most of the 2,2-difluoroputrescine was rapidly excreted in the urine, and formation of a conjugate was detected. 6,6-Difluorospermidine was also a urinary excretion product. However, the metabolic fate of 6,6-difluorospermine could not be clarified. It was not found in urine, either free or as conjugate. The relatively low accumulation of chain-fluorinated polyamines, together with their rapid elimination from normal tissues are characteristics which together with their previously established selective uptake into rapidly proliferating tissues recommend them as potential tumor markers that can be determined by 19F-NMR spectroscopy.
这项工作的目的是研究天然多胺的氟取代类似物在健康实验动物中的某些代谢方面,以探索它们作为肿瘤标志物的潜在应用。与单独使用鸟氨酸脱羧酶不可逆抑制剂D,L-α-二氟甲基鸟氨酸或多胺氧化酶失活剂N1,N4-双烯丙基腐胺相比,联合使用这两种抑制剂能更有效地降低组织中的多胺浓度。这表明多胺相互转化作为腐胺代谢来源的普遍重要性。在用这两种抑制剂预处理2周后给予2,2-二氟腐胺,几乎在所有组织中都导致了6,6-二氟亚精胺和6,6-二氟精胺的形成。在小肠中观察到链状氟化多胺的浓度最高。在给予2,2-二氟腐胺后24小时,小肠中的量约为正常内源性多胺池的8%,但在所有其他组织中较低。内源性多胺池的补充是一个相对缓慢的过程。在停止使用这两种抑制剂治疗后约9天,恢复了正常值。内源性多胺的形成速率不受其二氟类似物存在的影响。组织中链状氟化多胺的消除似乎不遵循正常的多胺代谢模式。它们最快速的消除与内源性多胺的增加同时发生,表明氟类似物被天然多胺取代。大部分2,2-二氟腐胺迅速经尿液排出,并检测到一种结合物的形成。6,6-二氟亚精胺也是尿液排泄产物。然而,6,6-二氟精胺的代谢命运尚不清楚。在尿液中未发现游离或结合形式的它。链状氟化多胺相对较低的积累以及它们从正常组织中的快速消除,这些特征连同它们先前确定的对快速增殖组织的选择性摄取,使它们成为可通过19F-NMR光谱测定的潜在肿瘤标志物。